| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Mar 7, 2025 | Buy(P) | 102 | $0.55 | $56 | 754K |
| Mar 4, 2025 | Buy(P) | 4K | $0.58 | $2K | 754K |
| Feb 28, 2025 | Buy(P) | 13K | $0.60 | $8K | 750K |
| Feb 27, 2025 | Buy(P) | 385 | $0.61 | $235 | 737K |
| Feb 26, 2025 | Buy(P) | 6K | $0.61 | $4K | 737K |
| Feb 25, 2025 | Buy(P) | 25K | $0.62 | $16K | 730K |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001398344-25-007139) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for NovaBay Pharmaceuticals, Inc.
This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/filing/0001398344-25-007139"
Use Arkolith to summarize insider buying and selling at NovaBay Pharmaceuticals, Inc. over the last 90 days and cite the filings.